Korean J Reprod Med.  2009 Mar;36(1):45-53.

Optimized Methods to Maintain Motility and Viability in Normozoospermic Males

Affiliations
  • 1Department of Animal Science & Technology, Chung-Ang University, Korea. mgpang@cau.ac.kr
  • 2BET Research Institute, Chung-Ang University, Korea.

Abstract


OBJECTIVES
To determinate the optimal culture condition to maintain lifespan in human sperm, we evaluated the effect of different temperature on sperm motility and viability up to 5 days in normal specimens.
METHODS
Ejaculated semen samples with normal semen parameters were gently washed in HEPES buffered Tyrod's-AlbuminLactate-Pyruvate (HTALP) media. Each 5 ml of HTALP + 0.3% albumin with 1x10(6) sperm/ml was incubated for 5 days in 37degrees C, 22degrees C, and 4degrees C. The sperm motility and kinematics were analyzed using computer assisted sperm analysis (CASA), membrane integrity was assessed by hypoosmotic swelling test (HOST), and capacitation status was evaluated by chlorotetracycline (CTC) fluorescence pattern. Each parameter was measured on day 1, 3, and 5, respectively.
RESULTS
The motility, viability and live/uncapacitated pattern were demonstrated significantly in temperature- and time-dependent difference (p<0.05). While the sperm cultured for 1 day in each temperature was not significantly different, the sperm cell kept in 22degrees C after 3 days were preserved sperm motility, viability, membrane integrity, and F pattern better than in other culture temperatures.
CONCLUSIONS
HTALP can be used a basic medium for culture and longevity preservation, and sperm cell kept at 22degrees C is beneficial for assisted reproductive techniques.

Keyword

Optimal sperm culture condition; Longevity; Motility; Preservation

MeSH Terms

Biomechanics
Chlortetracycline
Fluorescence
HEPES
Humans
Longevity
Male
Membranes
Reproductive Techniques, Assisted
Semen
Sperm Motility
Spermatozoa
Chlortetracycline
HEPES
Full Text Links
  • KJRM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr